BRAINTREE, Mass., April 26, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company will publish fourth quarter and full fiscal year 2017 financial results, and will provide guidance for fiscal year 2018, at 6:00am Eastern Time on Monday, May 8, 2017. The Company will hold a webcast conference call with investors and analysts to discuss results and guidance and to answer questions, at 8:00am Eastern Time on May 8, 2017.
Webcast Link: http://edge.media-server.com/m/p/6zwag47r
Webcast replay will be available from May 8, 2017 after 10:00am Eastern Time.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
INVESTOR CONTACT:
Gerry Gould, VP-Investor Relations
(781) 356-9402
gerry.gould@haemonetics.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-4th-quarter-and-full-fiscal-year-2017-results-and-for-providing-fiscal-2018-guidance-may-8-2017-300446538.html
SOURCE Haemonetics Corporation
